Gwangju Dementia Cohort Cohort

Building the evidence to overcome dementia — with data.

GARD builds a large-scale multi-omics cohort — integrating clinical, genomic, brain-imaging and biospecimen data — to study the early diagnosis and prevention of dementia.

Explore research About GARD

251TB+

Multi-omics data

23,000

Cohort participants

SCI

Int'l publications

Chosun UniversityMinistry of Science & ICTGwangjuKBRIBoston University

Research Pillars

From question to evidence, on one cohort.

01 · Cohort

Cohort building & operation

We follow a large community-based cohort over time to observe changes before and after dementia onset.

02 · Multi-omics

Integrated multi-omics analysis

We integrate genomic, imaging, fluid-biomarker and clinical data to uncover the causes and progression of dementia.

03 · Prevention

Early diagnosis & prevention

We identify risk at the pre-symptomatic stage and build the evidence base for prevention and intervention.

Cohort · participants

23,000

Multi-omics · layers

4 domains

Prevention · risk window

−15 yrs

Director's message

"We build the evidence to overcome dementia."

Dementia is no longer a challenge for individuals or single families alone. GARD follows participants from before symptoms appear and integrates clinical, genomic, brain-imaging and biospecimen data to build the evidence for early diagnosis and prevention.

Kun Ho Lee · Director, Gwangju Alzheimer's & Related Dementia Cohort

News

Latest from the cohort.

2026ResearchGARD cohort findings published in an international journal

2026NoticeMulti-omics data platform status released

2025ResearchAI-based brain imaging analysis results announced

Research collaboration & inquiries

We welcome inquiries on joint research, data use, and visits.